ADME Toxicology Testing Market is Projected to Grow by a Robust 10% through 2030 and Reach $11 billion

Industry Experts, Inc., has released its latest report on ADME Toxicology Testing Market. According this new report, the global market for ADME Toxicology Testing is estimated at US$6.3 billion in 2024 and is projected to reach US$11.2 billion by 2030, with a CAGR of 10.13% during the forecast period 2024-2030.

The global ADME toxicology testing market is experiencing rapid growth, fueled by the rising rates of drug failures in late-stage clinical trials, the growing demand for innovative and personalized therapies, and more stringent regulatory conditions worldwide. ADME testing is essential for assessing pharmacokinetics, toxicokinetics, and potential toxicity early in the drug development process, which helps mitigate expensive failures and enhances safety profiles. Pharmaceutical companies are increasing their research and development spending to create safer treatments for chronic illnesses, including cancer, diabetes, and heart disease. Technological advances including high-throughput screening, in silico modeling, AI-driven platforms, and organ-on-a-chip systems are making ADME evaluations faster, more accurate, and more cost-effective.

Cell culture technology leads the ADME toxicology testing market, capturing a 42.6% market share in 2024 due to its ability to closely replicate human physiological conditions. Innovative solutions such as 3D cell cultures, organ-on-chip technologies, and fluorometric imaging assays enhance predictive precision, minimize reliance on animal testing, and speed up the drug development process. The integration of AI and machine learning enhances efficiency and decision-making, while Ultra ADME testing supports the shift from 2D to 3D systems.

The report studies the ADME Toxicology Testing market across all major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.

The market for key technologies of ADME Toxicology Testing analyzed in this report include Cell Culture, High-Throughput Screening (HTS), Molecular Imaging and OMICS Technology. The report includes the market analysis of ADME toxicology testing by method for Cellular Assay, Biochemical Assay, In Silico and Ex vivo. The study also examines the market for ADME toxicology testing applications comprising Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Other Applications (Including Respiratory, Cardiovascular, Reproductive, Skin and other toxicities).

About Industry Experts, Inc
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/

Comments

Popular posts from this blog

Demand for Europium to Reach US$373.3 million by 2030 Fostered by Phosphors and Consumer Electronic Applications

Oil & Gas Fuels Demand for Duplex Stainless Steel and Global Market to Reach $6 billion by 2030

Copper Demand to Reach US$368.8 B by 2030 Propelled by the Wide Range of Applications of the Metal Across Sectors